NCT02389647View on ClinicalTrials.gov

Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 24, 2019

Study Completion Date

October 24, 2019

Conditions
Cerebral Ischemia
Trial Locations (1)

85013

St. Joseph's Hospital and Medical Center/Barrow Neurological Institute, Phoenix

All Listed Sponsors
collaborator

Translational Genomics Research Institute

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

St. Joseph's Hospital and Medical Center, Phoenix

OTHER

NCT02389647 - Identification of Novel Molecular Markers for Cerebral Ischemia From Patients With Minor and Devastating Ischemic Injury | Biotech Hunter | Biotech Hunter